欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NO/H/0314/002
药品名称
Atsteinar
活性成分
atorvastatin calcium salt 20.72 mg
剂型
Film-coated tablet
上市许可持有人
Actavis Group PTC ehf. Reykjavikurvegur 76-78 220 Hafnarfjordur Iceland
参考成员国 - 产品名称
Norway (NO)
互认成员国 - 产品名称
许可日期
2009/02/25
最近更新日期
2023/06/07
药物ATC编码
C10AA05 atorvastatin
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
PAR
|
parmod5_dk1413atsteinar_pdf
Date of last change:2022/06/02
Final PL
|
Atorvastatin-DK_H_1413_001-004-PIL-08.04.19
Date of last change:2019/06/19
Final SPC
|
Atorvastatin-DK_H_1413_001-004-SmPC-08.04.19
Date of last change:2019/06/19
Final Labelling
|
Atorvastatin-DK_H_1413_002-OuP+ImP-25.07.18
Date of last change:2019/02/08
Final Labelling
|
Atorvastatin-DK_H_1413_001-OuP+ImP-25.07.18
Date of last change:2019/02/08
Final Labelling
|
Atorvastatin-DK_H_1413_003-OuP+ImP-25.08.18
Date of last change:2019/02/08
Final Labelling
|
Atorvastatin-DK_H_1413_004-OuP+ImP-25.07.18
Date of last change:2019/02/08
Final Product Information
|
PI-Atorvastatin-DK_H_1413_01.04-P001-v4.1-20180131-CL
Date of last change:2018/07/10
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase